AusPAR: Human papillomavirus (Types 6, 11, 16 & 18) quadrivalent recombinant vaccine
Related information
- Australian Public Assessment Reports for prescription medicines (AusPARs)
- Browse AusPARs by active ingredient
- Browse AusPARs by product name
- Browse AusPARs by sponsor
How to access a pdf or Word document
*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.
Australian Public Assessment Report
7 June 2012
| AusPAR | |
|---|---|
| Active Ingredient | Human papillomavirus (Types 6, 11, 16 & 18) quadrivalent recombinant vaccine
|
| Product Name | Gardasil
|
| Sponsor | Merck Sharp & Dohme (Australia) Pty Ltd
|
| Submission Number | PM-2010-03191-3-2
|
| Submission Type | Extension of indications
|
| AusPAR Date | 7 May 2012
|
| Publication Date | 7 June 2012 |